Leak concerns fuelled release of Covid-19 drug data, says Anthony Fauci
The White House announcement of positive remdesivir results has concerned scientists
30 April 2020 - 09:03
Chicago — Concern over leaks compelled the top US infectious disease official to reveal data on Gilead Sciences’s experimental drug remdesivir, the first in a scientifically rigorous clinical trial to show benefit in treating Covid-19.
The dramatic announcement by Dr Anthony Fauci in the Oval Office on Wednesday prompted concerns among scientists that the Trump administration was raising hopes about a coronavirus treatment before sharing the full data with researchers...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.